anp chart, page-484

In one of Mac9’s posts some time back, he said something I remember that is very poignant now IMO.

He said he can sleep at night and not worry about the short term ANP SP movement, because he has only invested, in a relatively speculative company that ANP is, an amount that he can live with losing in entirety (I.e. all of his invested capital).

Platinum have less than 0.7% of their Healthcare Fund invested in ANP (at last report). This is not CSL. Or a forum competition to swing the largest shareholding.

Apologies if that came off sanctimonious, I want the best for the company, and all shareholders, but am mindful that failure to:

(1) fund a drug to commerciality (wow $1 bill required)
(2) get another company to help partner (fund) a drug (or combo) to commerciality
(3) be bought out by a company that can fund our drug(s) to commerciality or
(4) meet trial(s) endpoints

…could lead to zero ROI

I’m however optimistic that behind the scenes, given the changes that occurred Sep 2022 to now, that there is something going on that the company is not able to fully divulge yet.